Rejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosedFV
FemHealth Ventures
Activity from announced rounds
Activity in this selectionSeries A
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $73M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosed